• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三核苷酸帽类似物与三磷酸链修饰:作为 mRNA 加帽试剂的合成、性质和评估。

Trinucleotide cap analogs with triphosphate chain modifications: synthesis, properties, and evaluation as mRNA capping reagents.

机构信息

Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, Pasteura 5, 02-093 Warsaw, Poland.

Centre of New Technologies, University of Warsaw, Banacha 2C, 02-097 Warsaw, Poland.

出版信息

Nucleic Acids Res. 2024 Oct 14;52(18):10788-10809. doi: 10.1093/nar/gkae763.

DOI:10.1093/nar/gkae763
PMID:39248095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11472058/
Abstract

The recent COVID-19 pandemics have demonstrated the great therapeutic potential of in vitro transcribed (IVT) mRNAs, but improvements in their biochemical properties, such as cellular stability, reactogenicity and translational activity, are critical for further practical applications in gene replacement therapy and anticancer immunotherapy. One of the strategies to overcome these limitations is the chemical modification of a unique mRNA 5'-end structure, the 5'-cap, which is responsible for regulating translation at multiple levels. This could be achieved by priming the in vitro transcription reaction with synthetic cap analogs. In this study, we combined a highly efficient trinucleotide IVT capping technology with several modifications of the 5' cap triphosphate bridge to synthesize a series of 16 new cap analogs. We also combined these modifications with epigenetic marks (2'-O-methylation and m6Am) characteristic of mRNA 5'-ends in higher eukaryotes, which was not possible with dinucleotide caps. All analogs were compared for their effect on the interactions with eIF4E protein, IVT priming, susceptibility to decapping, and mRNA translation efficiency in model cell lines. The most promising α-phosphorothiolate modification was also evaluated in an in vivo mouse model. Unexpected differences between some of the analogs were analyzed using a protein cell extract pull-down assay.

摘要

最近的 COVID-19 大流行展示了体外转录(IVT)mRNA 的巨大治疗潜力,但提高其生化特性,如细胞稳定性、反应原性和翻译活性,对于基因替代治疗和抗癌免疫治疗的进一步实际应用至关重要。克服这些限制的策略之一是对独特的 mRNA 5'端结构(5'-帽)进行化学修饰,该结构负责在多个水平上调节翻译。这可以通过用合成帽类似物启动体外转录反应来实现。在这项研究中,我们将高效的三核苷酸 IVT 封端技术与 5'帽三磷酸桥的几种修饰相结合,合成了一系列 16 种新的帽类似物。我们还将这些修饰与真核生物 mRNA 5'端特有的表观遗传标记(2'-O-甲基化和 m6Am)相结合,这是二核苷酸帽无法做到的。在模型细胞系中,比较了所有类似物对与 eIF4E 蛋白相互作用、IVT 引发、脱帽敏感性和 mRNA 翻译效率的影响。还在体内小鼠模型中评估了最有前途的α-硫代磷酸酯修饰。使用蛋白细胞提取物下拉测定分析了一些类似物之间的一些意外差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/b3fbf7c2b202/gkae763fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/4cc98f28a7f9/gkae763figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/a84caf81adb2/gkae763fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/6c192a4c2ea6/gkae763fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/62f9eb0c8c8b/gkae763fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/6a0755bf77ca/gkae763fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/bff88d8beebe/gkae763fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/14d14ff4a444/gkae763fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/b3fbf7c2b202/gkae763fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/4cc98f28a7f9/gkae763figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/a84caf81adb2/gkae763fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/6c192a4c2ea6/gkae763fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/62f9eb0c8c8b/gkae763fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/6a0755bf77ca/gkae763fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/bff88d8beebe/gkae763fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/14d14ff4a444/gkae763fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1d/11472058/b3fbf7c2b202/gkae763fig7.jpg

相似文献

1
Trinucleotide cap analogs with triphosphate chain modifications: synthesis, properties, and evaluation as mRNA capping reagents.三核苷酸帽类似物与三磷酸链修饰:作为 mRNA 加帽试剂的合成、性质和评估。
Nucleic Acids Res. 2024 Oct 14;52(18):10788-10809. doi: 10.1093/nar/gkae763.
2
mRNA cap analogues substituted in the tetraphosphate chain with CX2: identification of O-to-CCl2 as the first bridging modification that confers resistance to decapping without impairing translation.在四磷酸链中被CX2取代的mRNA帽类似物:将O替换为CCl2作为首个赋予抗去帽能力且不损害翻译的桥连修饰的鉴定。
Nucleic Acids Res. 2017 Sep 6;45(15):8661-8675. doi: 10.1093/nar/gkx569.
3
Recent Advances in Modified Cap Analogs: Synthesis, Biochemical Properties, and mRNA Based Vaccines.改性帽类似物的最新进展:合成、生化特性和基于 mRNA 的疫苗。
Chem Rec. 2022 Aug;22(8):e202200005. doi: 10.1002/tcr.202200005. Epub 2022 Apr 14.
4
Synthesis, properties, and biological activity of boranophosphate analogs of the mRNA cap: versatile tools for manipulation of therapeutically relevant cap-dependent processes.mRNA帽的硼磷酸酯类似物的合成、性质及生物活性:用于调控与治疗相关的帽依赖性过程的通用工具。
Nucleic Acids Res. 2014;42(16):10245-64. doi: 10.1093/nar/gku757. Epub 2014 Aug 22.
5
Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency.用于体外合成具有高翻译效率的mRNA的新型帽类似物。
RNA. 2004 Sep;10(9):1479-87. doi: 10.1261/rna.7380904.
6
High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.对哺乳动物起始因子4E具有高亲和力的RNA会干扰mRNA帽结合并抑制翻译。
RNA. 2005 Jan;11(1):77-89. doi: 10.1261/rna.7108205.
7
Novel "anti-reverse" cap analogs with superior translational properties.具有卓越翻译特性的新型“抗反转”帽类似物。
RNA. 2003 Sep;9(9):1108-22. doi: 10.1261/rna.5430403.
8
The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5' cap modulates protein expression in living cells.真核生物 mRNA 5' 帽转录起始核苷酸的身份和甲基化状态调节活细胞中的蛋白质表达。
Nucleic Acids Res. 2020 Feb 28;48(4):1607-1626. doi: 10.1093/nar/gkaa032.
9
Photoactivatable mRNA 5' Cap Analogs for RNA-Protein Crosslinking.光活化的 mRNA 5' 帽类似物用于 RNA-蛋白质交联。
Adv Sci (Weinh). 2024 Sep;11(36):e2400994. doi: 10.1002/advs.202400994. Epub 2024 Jul 24.
10
Thermodynamics of molecular recognition of mRNA 5' cap by yeast eukaryotic initiation factor 4E.mRNA 5' 帽结构被酵母真核起始因子 4E 分子识别的热力学。
J Phys Chem B. 2011 Jul 14;115(27):8746-54. doi: 10.1021/jp2012039. Epub 2011 Jun 22.

本文引用的文献

1
Trinucleotide mRNA Cap Analogue 6-Benzylated at the Site of Posttranscriptional A Mark Facilitates mRNA Purification and Confers Superior Translational Properties In Vitro and In Vivo.三核苷酸 mRNA 帽类似物在转录后 A 位 6-苄基化,有助于 mRNA 纯化,并赋予体外和体内优越的翻译性能。
J Am Chem Soc. 2024 Mar 27;146(12):8149-8163. doi: 10.1021/jacs.3c12629. Epub 2024 Mar 5.
2
Chemical Modifications of mRNA Ends for Therapeutic Applications.mRNA 末端的化学修饰及其治疗应用。
Acc Chem Res. 2023 Oct 17;56(20):2814-2826. doi: 10.1021/acs.accounts.3c00442. Epub 2023 Oct 2.
3
Messenger RNA chromatographic purification: advances and challenges.
信使 RNA 色谱纯化:进展与挑战。
J Chromatogr A. 2023 Sep 27;1707:464321. doi: 10.1016/j.chroma.2023.464321. Epub 2023 Aug 21.
4
Characterization of mRNA therapeutics.mRNA疗法的特性描述。
Mass Spectrom Rev. 2024 Sep-Oct;43(5):1066-1090. doi: 10.1002/mas.21856. Epub 2023 Jul 4.
5
mRNA-based cancer therapeutics.mRNA 癌症疗法。
Nat Rev Cancer. 2023 Aug;23(8):526-543. doi: 10.1038/s41568-023-00586-2. Epub 2023 Jun 13.
6
Towards superior mRNA caps accessible by click chemistry: synthesis and translational properties of triazole-bearing oligonucleotide cap analogs.迈向可通过点击化学获得的优质信使核糖核酸帽:含三唑的寡核苷酸帽类似物的合成及翻译特性
RSC Adv. 2023 Apr 25;13(19):12809-12824. doi: 10.1039/d3ra00026e. eCollection 2023 Apr 24.
7
Regulation of Gene Expression by m6Am RNA Modification.m6Am RNA 修饰调控基因表达。
Int J Mol Sci. 2023 Jan 23;24(3):2277. doi: 10.3390/ijms24032277.
8
Click-iT trinucleotide cap analog: Synthesis, mRNA translation, and detection.Click-iT三核苷酸帽类似物:合成、mRNA翻译及检测
Bioorg Med Chem. 2023 Jan 1;77:117128. doi: 10.1016/j.bmc.2022.117128. Epub 2022 Dec 10.
9
The ProteomeXchange consortium at 10 years: 2023 update.蛋白质组交换联盟成立十周年:2023 年更新。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1539-D1548. doi: 10.1093/nar/gkac1040.
10
Unlocking the promise of mRNA therapeutics.解锁 mRNA 疗法的潜力。
Nat Biotechnol. 2022 Nov;40(11):1586-1600. doi: 10.1038/s41587-022-01491-z. Epub 2022 Nov 3.